Page last updated: 2024-08-21

isoxazoles and Atrophy

isoxazoles has been researched along with Atrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atkins, CM; Chapalamadugu, M; Gee, KW; Hogenkamp, D; Johnson, NH; Johnstone, T; London, SH; Titus, DJ1
Bellamy, CO; Dhaun, N; Kluth, DC; MacIntyre, IM1

Other Studies

2 other study(ies) available for isoxazoles and Atrophy

ArticleYear
Positive allosteric modulation of the α7 nicotinic acetylcholine receptor as a treatment for cognitive deficits after traumatic brain injury.
    PloS one, 2019, Volume: 14, Issue:10

    Topics: Allosteric Regulation; alpha7 Nicotinic Acetylcholine Receptor; Anilides; Animals; Atrophy; Brain; Brain Injuries, Traumatic; Chronic Disease; Cognition Disorders; Conditioning, Classical; Fear; Isoxazoles; Long-Term Potentiation; Male; Maze Learning; Memory, Short-Term; Rats, Sprague-Dawley; Synaptic Transmission

2019
Endothelin receptor antagonism and renin inhibition as treatment options for scleroderma kidney.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2009, Volume: 54, Issue:4

    Topics: Amides; Antihypertensive Agents; Atrophy; Biomarkers; Biopsy; Endothelin Receptor Antagonists; Female; Fibrosis; Fumarates; Humans; Hypertension, Renal; Isoxazoles; Kidney; Middle Aged; Proteinuria; Pulmonary Fibrosis; Renal Insufficiency, Chronic; Renin; Scleroderma, Systemic; Thiophenes; Treatment Outcome

2009